+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Expansion: Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5141005

Global Cell Expansion Market to Reach $77.5 Billion by 2030

The global market for Cell Expansion estimated at US$25.8 Billion in the year 2022, is projected to reach a revised size of US$77.5 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 16% CAGR and reach US$38.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.8 Billion, While China is Forecast to Grow at 14% CAGR

The Cell Expansion market in the U.S. is estimated at US$7.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$13.1 Billion by the year 2030 trailing a CAGR of 14% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.6% and 11.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Select Competitors (Total 12 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cell Expansion - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Human Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Human Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Animal Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Animal Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Cell Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Cell Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Cell Expansion Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 12: World Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 13: World 8-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 15: World 8-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 19: World 8-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 21: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 22: USA Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 23: USA 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 24: USA Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
CANADA
  • Table 28: Canada Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 29: Canada 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 30: Canada Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
JAPAN
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 34: Japan Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 35: Japan 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 37: Japan 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
CHINA
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 40: China Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 41: China 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 42: China Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 43: China 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: China 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
EUROPE
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 46: Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 47: Europe 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 48: Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 49: Europe 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Cell Expansion by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 51: Europe 8-Year Perspective for Cell Expansion by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 53: Europe 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
FRANCE
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 54: France Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 55: France 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: France 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 59: France 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
GERMANY
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 60: Germany Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 61: Germany 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 65: Germany 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
ITALY
  • Table 66: Italy Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 67: Italy 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 71: Italy 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
UNITED KINGDOM
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 72: UK Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 73: UK 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: UK 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 77: UK 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
REST OF EUROPE
  • Table 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 79: Rest of Europe 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Rest of Europe 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 83: Rest of Europe 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
ASIA-PACIFIC
  • Cell Expansion Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 85: Asia-Pacific 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Asia-Pacific 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 89: Asia-Pacific 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
REST OF WORLD
  • Table 90: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Cell Type - Human Cells and Animal Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 91: Rest of World 8-Year Perspective for Cell Expansion by Cell Type - Percentage Breakdown of Value Sales for Human Cells and Animal Cells for the Years 2023 & 2030
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by End-Use - Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of World 8-Year Perspective for Cell Expansion by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharma & Biotech Companies, Cell Banks and Other End-Uses for the Years 2023 & 2030
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Cell Expansion by Component - Consumables, Instruments and Disposables - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 95: Rest of World 8-Year Perspective for Cell Expansion by Component - Percentage Breakdown of Value Sales for Consumables, Instruments and Disposables for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Corning, Inc.
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KgaA
  • MilliporeSigma
  • Miltenyi Biotec GmbH
  • StemCell Technologies Inc.
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific, Inc.

Table Information